The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-benzylureido)-N-(4-sulfamoylbenzyl)-butanamide ID: ALA3360588
PubChem CID: 118724329
Max Phase: Preclinical
Molecular Formula: C19H24N4O4S
Molecular Weight: 404.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(CNC(=O)CCCNC(=O)NCc2ccccc2)cc1
Standard InChI: InChI=1S/C19H24N4O4S/c20-28(26,27)17-10-8-16(9-11-17)13-22-18(24)7-4-12-21-19(25)23-14-15-5-2-1-3-6-15/h1-3,5-6,8-11H,4,7,12-14H2,(H,22,24)(H2,20,26,27)(H2,21,23,25)
Standard InChI Key: JCCDIFAGFKPVRO-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
8.8928 -18.1226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6005 -17.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3082 -18.1226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0159 -17.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8928 -18.9398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1851 -17.7140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1851 -16.8968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4774 -16.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7697 -16.8968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0620 -16.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0620 -15.6710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7697 -15.2624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4774 -15.6710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7236 -18.1226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4313 -17.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1390 -18.1226 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4313 -16.8968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1390 -16.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8468 -16.8968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5545 -16.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2622 -16.8968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2622 -17.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5545 -18.1226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8468 -17.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9797 -14.5249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3664 -15.2453 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.7968 -14.5502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6467 -15.6392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
1 5 2 0
1 6 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
8 13 2 0
6 7 1 0
14 15 1 0
15 16 2 0
15 17 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
17 18 1 0
4 14 1 0
26 25 2 0
27 26 2 0
11 26 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.49Molecular Weight (Monoisotopic): 404.1518AlogP: 1.23#Rotatable Bonds: 9Polar Surface Area: 130.39Molecular Species: NEUTRALHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.22CX Basic pKa: ┄CX LogP: 0.56CX LogD: 0.56Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.47Np Likeness Score: -1.37
References 1. Ceruso M, Antel S, Vullo D, Scozzafava A, Supuran CT.. (2014) Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV., 22 (24): [PMID:25468040 ] [10.1016/j.bmc.2014.10.041 ]